Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
Valdez
H
H
Gripshover
B M
BM
Salata
R A
RA
Lederman
M M
MM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000150:complications / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans
D019380:Anti-HIV Agents; D000935:Antifungal Agents; D015725:Fluconazole